[
  {
    "ts": null,
    "headline": "Will Higher Royalties From Partners Fuel HALO's Growth in H2 2025?",
    "summary": "Halozyme boosts its 2025 revenue outlook on surging royalties from Darzalex SC, Phesgo and Vyvgart Hytrulo, though partner reliance persists.",
    "url": "https://finnhub.io/api/news?id=cb4b88f471e475eed4e5f443c75072ce0a0e3099cb12c087d882f9bc4451513c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761228060,
      "headline": "Will Higher Royalties From Partners Fuel HALO's Growth in H2 2025?",
      "id": 137197765,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Halozyme boosts its 2025 revenue outlook on surging royalties from Darzalex SC, Phesgo and Vyvgart Hytrulo, though partner reliance persists.",
      "url": "https://finnhub.io/api/news?id=cb4b88f471e475eed4e5f443c75072ce0a0e3099cb12c087d882f9bc4451513c"
    }
  },
  {
    "ts": null,
    "headline": "AngioInsight Appoints Medtech Veteran Shlomi Nachman to Board of Directors; Announces Series A Round to Accelerate AI-Driven Advancement in Cardiology",
    "summary": "MINNETONKA, Minn., October 23, 2025--AngioInsight, a leader in AI-powered cardiovascular diagnostics, today announced the appointment of Shlomi Nachman, former Worldwide Chairman of Johnson & Johnson’s Cardiovascular and Specialty Solutions (CSS), to its Board of Directors. AngioInsight is further announcing initiation of its Series A round of $25M, following the successful closing of its oversubscribed seed funding round. The investment will support the ongoing development of AngioAI+™, the com",
    "url": "https://finnhub.io/api/news?id=0a06d91aee04b520ec4f822482d89797331365e77377852a9ebba6909a927144",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761220800,
      "headline": "AngioInsight Appoints Medtech Veteran Shlomi Nachman to Board of Directors; Announces Series A Round to Accelerate AI-Driven Advancement in Cardiology",
      "id": 137197766,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "MINNETONKA, Minn., October 23, 2025--AngioInsight, a leader in AI-powered cardiovascular diagnostics, today announced the appointment of Shlomi Nachman, former Worldwide Chairman of Johnson & Johnson’s Cardiovascular and Specialty Solutions (CSS), to its Board of Directors. AngioInsight is further announcing initiation of its Series A round of $25M, following the successful closing of its oversubscribed seed funding round. The investment will support the ongoing development of AngioAI+™, the com",
      "url": "https://finnhub.io/api/news?id=0a06d91aee04b520ec4f822482d89797331365e77377852a9ebba6909a927144"
    }
  },
  {
    "ts": null,
    "headline": "Nanobiotix S.A: Behind The Recent Momentum",
    "summary": "Despite potential blockbuster royalties, NBTX's $1.1B stock valuation appears stretched due to limited pipeline and reliance on J&J for development. Read the full analysis here.",
    "url": "https://finnhub.io/api/news?id=0127b2e224e3f5a2e06d17c9ba056b5729805fc2de7402af0ef893528c008f4b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761215085,
      "headline": "Nanobiotix S.A: Behind The Recent Momentum",
      "id": 137196767,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1281832252/image_1281832252.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Despite potential blockbuster royalties, NBTX's $1.1B stock valuation appears stretched due to limited pipeline and reliance on J&J for development. Read the full analysis here.",
      "url": "https://finnhub.io/api/news?id=0127b2e224e3f5a2e06d17c9ba056b5729805fc2de7402af0ef893528c008f4b"
    }
  },
  {
    "ts": null,
    "headline": "GCC $1.25+ Bn Catheter Market Growth Trends and Forecast to 2033 Featuring Abbott, Edwards Lifesciences, BD and Co, Boston Scientific, Medtronic, Johnson & Johnson, Stryker, Teleflex",
    "summary": "The GCC catheter market is projected to grow from USD 579.83 million in 2024 to USD 1.28 billion by 2033, with a CAGR of 9.21% from 2025 to 2033. This growth is driven by an increase in chronic diseases, surgical procedures, and advanced healthcare infrastructure across GCC countries. The demand for minimally invasive treatments and the aging population further bolster market expansion. Key sectors such as cardiovascular, microcatheters, and intermittent catheters are witnessing significant grow",
    "url": "https://finnhub.io/api/news?id=fce5d1ea8f0bddc4ec9de6a99102bb87c65387bd0a9313713100f27104bcde46",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761210540,
      "headline": "GCC $1.25+ Bn Catheter Market Growth Trends and Forecast to 2033 Featuring Abbott, Edwards Lifesciences, BD and Co, Boston Scientific, Medtronic, Johnson & Johnson, Stryker, Teleflex",
      "id": 137197767,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The GCC catheter market is projected to grow from USD 579.83 million in 2024 to USD 1.28 billion by 2033, with a CAGR of 9.21% from 2025 to 2033. This growth is driven by an increase in chronic diseases, surgical procedures, and advanced healthcare infrastructure across GCC countries. The demand for minimally invasive treatments and the aging population further bolster market expansion. Key sectors such as cardiovascular, microcatheters, and intermittent catheters are witnessing significant grow",
      "url": "https://finnhub.io/api/news?id=fce5d1ea8f0bddc4ec9de6a99102bb87c65387bd0a9313713100f27104bcde46"
    }
  },
  {
    "ts": null,
    "headline": "Inside The Dow: Key Earnings Ahead For Some Of The Index's YTD Winners",
    "summary": "Caterpillar shares have jumped to a sizable lead among the Dow 30 YTD, and the Texas company reports Q3 results next week.",
    "url": "https://finnhub.io/api/news?id=37708c8b85f7b4510bb31d9ecddec667d54496a8a6cc510195757962e0c5d35e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761186600,
      "headline": "Inside The Dow: Key Earnings Ahead For Some Of The Index's YTD Winners",
      "id": 137194612,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1854380206/image_1854380206.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Caterpillar shares have jumped to a sizable lead among the Dow 30 YTD, and the Texas company reports Q3 results next week.",
      "url": "https://finnhub.io/api/news?id=37708c8b85f7b4510bb31d9ecddec667d54496a8a6cc510195757962e0c5d35e"
    }
  },
  {
    "ts": null,
    "headline": "Freedom Capital Markets Downgrades Johnson & Johnson (JNJ)",
    "summary": "Freedom Capital Markets Downgrades Johnson & Johnson (JNJ)",
    "url": "https://finnhub.io/api/news?id=27b7501c73e78849b0ccca269759b0abb9bec98981df448d29b339c0296b05b9",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761177782,
      "headline": "Freedom Capital Markets Downgrades Johnson & Johnson (JNJ)",
      "id": 137193354,
      "image": "",
      "related": "JNJ",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=27b7501c73e78849b0ccca269759b0abb9bec98981df448d29b339c0296b05b9"
    }
  }
]